Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Monoamine oxidase-A knockdown in human neuroblastoma cells reveals protection against mitochondrial toxins.

Fitzgerald JC, Ugun-Klusek A, Allen G, De Girolamo LA, Hargreaves I, Ufer C, Abramov AY, Billett EE.

FASEB J. 2014 Jan;28(1):218-29. doi: 10.1096/fj.13-235481. Epub 2013 Sep 19.

PMID:
24051032
2.

Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells.

Fitzgerald JC, Ufer C, De Girolamo LA, Kuhn H, Billett EE.

J Neurochem. 2007 Dec;103(6):2189-99. Epub 2007 Sep 18.

3.
4.

Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.

Yi H, Akao Y, Maruyama W, Chen K, Shih J, Naoi M.

J Neurochem. 2006 Jan;96(2):541-9. Epub 2005 Dec 8.

5.
6.

Parkin suppresses the expression of monoamine oxidases.

Jiang H, Jiang Q, Liu W, Feng J.

J Biol Chem. 2006 Mar 31;281(13):8591-9. Epub 2006 Feb 2.

7.

Oxidative alpha-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity: implications for Parkinson's disease.

Kumar MJ, Nicholls DG, Andersen JK.

J Biol Chem. 2003 Nov 21;278(47):46432-9. Epub 2003 Sep 8. Erratum in: J Biol Chem. 2004 Feb 27;279(9):8516.

8.

Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure.

Rhein V, Giese M, Baysang G, Meier F, Rao S, Schulz KL, Hamburger M, Eckert A.

PLoS One. 2010 Aug 24;5(8):e12359. doi: 10.1371/journal.pone.0012359.

9.

A link between monoamine oxidase-A and apoptosis in serum deprived human SH-SY5Y neuroblastoma cells.

Fitzgerald JC, Ufer C, Billett EE.

J Neural Transm (Vienna). 2007;114(6):807-10. Epub 2007 Mar 29.

PMID:
17393061
10.
11.

Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival.

Naoi M, Maruyama W, Inaba-Hasegawa K.

Curr Top Med Chem. 2012;12(20):2177-88. Review.

PMID:
23231395
13.

Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.

Perfeito R, Cunha-Oliveira T, Rego AC.

Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Review.

PMID:
23743292
14.

Mitochondrial function in human neuroblastoma cells is up-regulated and protected by NQO1, a plasma membrane redox enzyme.

Kim J, Kim SK, Kim HK, Mattson MP, Hyun DH.

PLoS One. 2013 Jul 11;8(7):e69030. doi: 10.1371/journal.pone.0069030. Print 2013.

15.

Reactive oxygen species production by monoamine oxidases in intact cells.

Pizzinat N, Copin N, Vindis C, Parini A, Cambon C.

Naunyn Schmiedebergs Arch Pharmacol. 1999 May;359(5):428-31.

PMID:
10498294
16.

Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease.

Khan FH, Sen T, Maiti AK, Jana S, Chatterjee U, Chakrabarti S.

Biochim Biophys Acta. 2005 Jun 30;1741(1-2):65-74. Epub 2005 Apr 14.

17.

Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis.

Pchejetski D, Kunduzova O, Dayon A, Calise D, Seguelas MH, Leducq N, Seif I, Parini A, Cuvillier O.

Circ Res. 2007 Jan 5;100(1):41-9. Epub 2006 Dec 7.

19.

Heptachlor induced mitochondria-mediated cell death via impairing electron transport chain complex III.

Hong S, Kim JY, Hwang J, Shin KS, Kang SJ.

Biochem Biophys Res Commun. 2013 Aug 9;437(4):632-6. doi: 10.1016/j.bbrc.2013.07.018. Epub 2013 Jul 15.

PMID:
23867817
20.

Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow.

Cohen G, Farooqui R, Kesler N.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):4890-4.

Supplemental Content

Support Center